Cover Image
Market Research Report

Europe Smart Inhalers Market Forecast 2019-2028

Published by Inkwood Research Product code 945450
Published Content info 122 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Smart Inhalers Market Forecast 2019-2028
Published: June 30, 2020 Content info: 122 Pages
Description

KEY FINDINGS

The Europe smart inhalers market is predicted to register a CAGR of 32.11% over the estimated period, 2019-2028. An increase in the incidence of COPD and asthma, a rise in awareness about these diseases, an increase in the geriatric population, and an upsurge in demand for new emerging technologies boost the market growth in the region.

MARKET INSIGHTS

The study of the Europe smart inhalers market growth is based on the market performance of Belgium, Russia, Germany, Italy, the UK, Poland, France, and the rest of Europe Denmark, Norway, Austria, Swede, Netherlands, and Spain. Italy spends about 9% of the GDP each year on healthcare as per OECD. The prevalence of respiratory diseases, with consistent healthcare expenditure on research activities, as well as contributions by societies to raise awareness, are expected to help in the steady growth of the market. In countries like Belgium, lifestyle disorders, such as smoking and alcohol consumption, are some of the crucial contributors to respiratory disorders, which require home healthcare services. There are growing initiatives to increase telereporting and teleconsultations, which propel the demand for inhalers and nebulizers in-home healthcare settings.

In Poland, the growing prevalence of cystic fibrosis, as well as rising COPD disease, is expected to augment the market growth. COPD is a major social burden, as 20 thousand disability pensions are granted every year, due to this disease. The rest of Europe also spend majorly on healthcare as per GDP about the median of OECD, which makes this region lucrative for market growth.

COMPETITIVE INSIGHTS

Some of the prominent companies operating in the market are GlaxoSmithKline Plc, Agilent Technologies Inc, 3M Company, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32373

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. RISE IN AIR POLLUTION
    • 3.2.2. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
    • 3.2.3. SURGING INDOOR AIR POLLUTANTS
    • 3.2.4. RISING GERIATRIC POPULATION
    • 3.2.5. GROWING PREVALENCE OF COPD AND ASTHMA
  • 3.3. KEY RESTRAINTS
    • 3.3.1. DATA SECURITY CONCERN HAMPERS THE MARKET
    • 3.3.2. HIGH COST OF ASTHMA AND COPD TREATMENT

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. EVOLUTION OF SMART INHALERS
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SMART INHALERS
  • 5.2. SMART NEBULIZER
    • 5.2.1. TYPES OF NEBULIZER (QUALITATIVE)
      • 5.2.1.1. PNEUMATIC NEBULIZER
      • 5.2.1.2. ULTRASONIC NEBULIZER
      • 5.2.1.3. MESH NEBULIZER
    • 5.2.2. NEBULIZER BY PORTABILITY (QUALITATIVE)
      • 5.2.2.1. TABLETOP NEBULIZER
      • 5.2.2.2. PORTABLE NEBULIZER
    • 5.2.3. NEBULIZER BY SALES CHANNEL (QUALITATIVE)
      • 5.2.3.1. DIRECT PURCHASE
      • 5.2.3.2. ONLINE PURCHASE

6. MARKET BY INDICATION

  • 6.1. ASTHMA
  • 6.2. COPD

7. MARKET BY DISTRIBUTION CHANNEL

  • 7.1. HOSPITAL
  • 7.2. PHARMACY

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. GERMANY
    • 8.1.2. FRANCE
    • 8.1.3. THE UNITED KINGDOM
    • 8.1.4. ITALY
    • 8.1.5. RUSSIA
    • 8.1.6. BELGIUM
    • 8.1.7. POLAND
    • 8.1.8. REST OF EUROPE

9. COMPANY PROFILES

  • 9.1. 3M COMPANY
  • 9.2. ADHERIUM LIMITED
  • 9.3. AGILENT TECHNOLOGIES INC
  • 9.4. ASTRAZENECA PLC
  • 9.5. BOEHRINGER INGELHEIM GMBH
  • 9.6. COHERO HEALTH INC
  • 9.7. GLAXOSMITHKLINE PLC
  • 9.8. KONINKLIJKE PHILIPS N.V.
  • 9.9. NOVARTIS AG
  • 9.10. OPKO HEALTH INC
  • 9.11. RESMED INC (PROPELLER HEALTH)
  • 9.12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • 9.13. VECTURA GROUP PLC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SMART INHALERS
  • TABLE 2: EUROPE SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 3: EUROPE SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 4: EUROPE SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 5: EUROPE SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 6: EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 7: EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 8: EUROPE SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 9: EUROPE SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: EUROPE SMART INHALERS MARKET, BY PRODUCT, IN 2019
  • FIGURE 6: EUROPE SMART INHALERS MARKET, BY SMART INHALERS, 2019-2028 (IN $ THOUSAND)
  • FIGURE 7: EUROPE SMART INHALERS MARKET, BY SMART NEBULIZER, 2019-2028 (IN $ THOUSAND)
  • FIGURE 8: EUROPE SMART INHALERS MARKET, BY INDICATION, IN 2019
  • FIGURE 9: EUROPE SMART INHALERS MARKET, BY ASTHMA, 2019-2028 (IN $ THOUSAND)
  • FIGURE 10: EUROPE SMART INHALERS MARKET, BY COPD, 2019-2028 (IN $ THOUSAND)
  • FIGURE 11: EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 12: EUROPE SMART INHALERS MARKET, BY HOSPITAL, 2019-2028 (IN $ THOUSAND)
  • FIGURE 13: EUROPE SMART INHALERS MARKET, BY PHARMACY, 2019-2028 (IN $ THOUSAND)
  • FIGURE 14: EUROPE SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 15: GERMANY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 16: FRANCE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 17: THE UNITED KINGDOM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 18: ITALY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 19: RUSSIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 20: BELGIUM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 21: POLAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 22: REST OF EUROPE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
Back to Top